neuroAD

Overview

The neuroAD system by Neuronix is an innovative, safe and effective non-pharmaceutical treatment alternative for mild to moderate Alzheimer’s Disease. It is the first medical device in the world cleared for this indication. [More]

Clinical Data

In clinical trials, neuroAD technology has shown measurable cognitive improvement after just a few weeks. The results showed marked reversal of disease progression. [More]

Treatment Protocol

Details of the pre-treatment, six week intensive treatment phase and post-treatment maintenance protocols. [More]

Shown to slow the degenerative progression of Alzheimer’s Disease
Evidenced safe and effective in peer-reviewed studies
Discovered to be superior to existing pharmaceuticals in the treatment of Alzheimer’s Disease
Regulatory (CE) approved technology for “treatment of mild to moderate Alzheimer’s Disease”
Known and described in literature mechanism of action
Ongoing clinical trials in Alzheimer’s patients and active R&D
Endorsed and backed by strong Scientific Advisory Board

NeuroAD is an investigational device, currently not available in the USA